首页> 外国专利> Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux

Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux

机译:抵抗P糖蛋白介导的药物外排的肽基前药

摘要

A method of treating a patient for a condition wherein the bioactive agent of choice is DRUG, wherein DRUG is a substrate that is effluxed by the P-gp transporter, is provided, the method comprising administering to the patient an effective amount of a compound of formula (I):DRUG-X—Y(n)—Z(n′)—Z′(n″)—R  (I)wherein each X, Y, Z, and Z′ is independently Met, Val, Thr, Tyr, Trp, Ser, Ala, or Gly; R is H or an amino-protecting group; n is 1, and each n′, or n″ is independently 0 or 1; or a pharmaceutically acceptable salt thereof, with the proviso that DRUG is not acyclovir or ganciclovir and that DRUG is non-peptidyl.
机译:提供了一种治疗患者的疾病的方法,其中选择的生物活性剂是DRUG,其中DRUG是被P-gp转运蛋白排出的底物,该方法包括向患者施用有效量的以下化合物:公式(I):<?in-line-formulae description =“在线公式” end =“ lead”?> DRUG-X-Y (n) -Z (n') —Z′(n'') —R(I)<?in-line-formulae description =“在线表达式” end =“ tail”?>其中每个X,Y,Z和Z'独立地为Met,Val,Thr,Tyr,Trp,Ser,Ala或Gly; R为H或氨基保护基; n为1,且每个n'或n''独立为0或1;或其药学上可接受的盐,条件是DRUG不是阿昔洛韦或更昔洛韦,DRUG不是肽基。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号